Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Shares Outstanding (Diluted Average): 2011-2025

Historic Shares Outstanding (Diluted Average) for Abeona Therapeutics (ABEO) over the last 4 years, with Sep 2025 value amounting to $65.8 million.

  • Abeona Therapeutics' Shares Outstanding (Diluted Average) rose 36.81% to $65.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.8 million, marking a year-over-year increase of 36.81%. This contributed to the annual value of $41.0 million for FY2024, which is 91.99% up from last year.
  • As of Q3 2025, Abeona Therapeutics' Shares Outstanding (Diluted Average) stood at $65.8 million, which was down 1.29% from $66.6 million recorded in Q2 2025.
  • Abeona Therapeutics' 5-year Shares Outstanding (Diluted Average) high stood at $66.6 million for Q2 2025, and its period low was $5.8 million during Q2 2022.
  • Over the past 3 years, Abeona Therapeutics' median Shares Outstanding (Diluted Average) value was $41.0 million (recorded in 2024), while the average stood at $39.2 million.
  • Data for Abeona Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY soared of 286.18% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Abeona Therapeutics' Shares Outstanding (Diluted Average) stood at $7.9 million in 2022, then surged by 171.96% to $21.4 million in 2023, then spiked by 91.99% to $41.0 million in 2024, then spiked by 36.81% to $65.8 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $65.8 million for Q3 2025, versus $66.6 million for Q2 2025 and $49.8 million for Q1 2025.